FR20C1038I1 - - Google Patents

Info

Publication number: FR20C1038I1
Authority: FR; France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-29

Filing date

2020-08-20

Publication date

2020-10-02

2020-08-20 Application filed filed Critical

2020-10-02 Publication of FR20C1038I1 publication Critical patent/FR20C1038I1/fr

2021-08-13 Application granted granted Critical

2021-08-13 Publication of FR20C1038I2 publication Critical patent/FR20C1038I2/fr

Status Active legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

FR20C1038C 2007-06-29 2020-08-20 Derives de benzamidazole Active FR20C1038I2 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US94728707P	2007-06-29	2007-06-29
US4164508P	2008-04-02	2008-04-02
PCT/IB2008/001575 WO2009004427A2 (fr)	2007-06-29	2008-06-16	Dérivés de benzamidazole

Publications (2)

Publication Number	Publication Date
FR20C1038I1 true FR20C1038I1 (fr)	2020-10-02
FR20C1038I2 FR20C1038I2 (fr)	2021-08-13

Family

ID=40161351

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR20C1038C Active FR20C1038I2 (fr)	2007-06-29	2020-08-20	Derives de benzamidazole

Country Status (46)

Country	Link
US (2)	US8148401B2 (fr)
EP (1)	EP2170860B9 (fr)
JP (2)	JP4567099B2 (fr)
KR (1)	KR101143246B1 (fr)
CN (1)	CN101687841B (fr)
AP (1)	AP2377A (fr)
AR (1)	AR067346A1 (fr)
AU (1)	AU2008272641B2 (fr)
BR (1)	BRPI0813412B8 (fr)
CA (1)	CA2690953C (fr)
CL (1)	CL2008001922A1 (fr)
CO (1)	CO6160232A2 (fr)
CR (1)	CR11150A (fr)
CU (1)	CU23847B1 (fr)
CY (2)	CY1118650T1 (fr)
DK (1)	DK2170860T5 (fr)
DO (1)	DOP2009000278A (fr)
EA (1)	EA016888B1 (fr)
EC (1)	ECSP099803A (fr)
ES (1)	ES2609258T3 (fr)
FR (1)	FR20C1038I2 (fr)
GE (1)	GEP20125702B (fr)
GT (1)	GT200900328A (fr)
HK (1)	HK1139658A1 (fr)
HN (1)	HN2008000974A (fr)
HR (1)	HRP20161562T2 (fr)
HU (2)	HUE030052T4 (fr)
IL (1)	IL202420A (fr)
LT (2)	LT2170860T (fr)
MA (1)	MA31466B1 (fr)
ME (1)	ME00962B (fr)
MY (1)	MY148636A (fr)
NI (1)	NI200900219A (fr)
NL (1)	NL301057I2 (fr)
NO (1)	NO2020027I1 (fr)
NZ (1)	NZ581889A (fr)
PA (1)	PA8785401A1 (fr)
PE (2)	PE20090772A1 (fr)
PL (1)	PL2170860T3 (fr)
PT (1)	PT2170860T (fr)
RS (1)	RS55395B9 (fr)
SI (1)	SI2170860T1 (fr)
TN (1)	TN2009000544A1 (fr)
TW (1)	TWI371451B (fr)
UY (1)	UY31164A1 (fr)
WO (1)	WO2009004427A2 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EA016888B1 (ru) *	2007-06-29	2012-08-30	Пфайзер Инк.	Производные бензимидазола
EP2330894B8 (fr)	2008-09-03	2017-04-19	BioMarin Pharmaceutical Inc.	Compositions comprenant des dérivés d acide 6-aminohexanoïque utilisées comme inhibiteurs de hdac
US8835648B2 (en) *	2009-06-11	2014-09-16	Siena Biotech S.P.A.	Hedgehog pathway antagonists and therapeutic applications thereof
JP5599802B2 (ja)	2009-08-26	2014-10-01	武田薬品工業株式会社	縮合複素環誘導体およびその用途
US10010439B2 (en)	2010-06-13	2018-07-03	Synerz Medical, Inc.	Intragastric device for treating obesity
US8628554B2 (en)	2010-06-13	2014-01-14	Virender K. Sharma	Intragastric device for treating obesity
US9526648B2 (en)	2010-06-13	2016-12-27	Synerz Medical, Inc.	Intragastric device for treating obesity
US10420665B2 (en)	2010-06-13	2019-09-24	W. L. Gore & Associates, Inc.	Intragastric device for treating obesity
WO2012052948A1 (fr)	2010-10-20	2012-04-26	Pfizer Inc.	Dérivés de pyridine-2 en tant que modulateurs des récepteurs smoothened
JP5452459B2 (ja)	2010-12-16	2014-03-26	株式会社Ｎｔｔドコモ	ホーム基地局及びハンドオーバ方法
JP6250403B2 (ja)	2011-02-28	2017-12-20	バイオマリンファーマシューティカルインク	ヒストン脱アセチル化酵素阻害剤
US8957066B2 (en)	2011-02-28	2015-02-17	Biomarin Pharmaceutical Inc.	Histone deacetylase inhibitors
US10059723B2 (en)	2011-02-28	2018-08-28	Biomarin Pharmaceutical Inc.	Histone deacetylase inhibitors
US9051305B2 (en)	2011-03-08	2015-06-09	Eutropics Pharmaceuticals, Inc.	Compositions and methods useful for treating diseases
FR2980477B1 (fr)	2011-09-23	2013-10-18	Centre Nat Rech Scient	Nouveaux composes modulateurs de la voie de signalisation des proteines hedgehog, leurs formes marquees, et applications
CA2849820C (fr) *	2011-09-26	2019-08-27	Merck Patent Gmbh	Composes de benzylpiperidine utilises comme antagonistes des recepteurs a l'acide lysophosphatidique (lpa)
EP2863920B1 (fr)	2012-06-20	2023-03-22	Eutropics Pharmaceuticals, Inc.	Dérivés de quinoline pour l'utilisation dans le traitement du cancer du sein
WO2014081953A1 (fr)	2012-11-21	2014-05-30	Richard David J	Méthodes et compositions utiles dans le traitement de maladies faisant appel à des protéines de la famille bcl-2 et des dérivés d'isoquinoléine et de quinoléine
KR20150132345A (ko)	2013-03-15	2015-11-25	바이오마린 파머수티컬 인크.	Hdac 저해제
US10435364B2 (en)	2013-04-17	2019-10-08	Albert Ludwigs Universität Freiburg	Compounds for use as bromodomain inhibitors
WO2015017788A1 (fr)	2013-08-01	2015-02-05	Eutropics Pharmaceuticals, Inc.	Méthode permettant de prédire la sensibilité d'un cancer
GB2519344A (en) *	2013-10-18	2015-04-22	Redx Pharma Ltd	Compounds
EP3063302B1 (fr)	2013-10-30	2019-12-04	Eutropics Pharmaceuticals, Inc.	Procédés de détermination de la chimiosensibilité et de la chimiotoxicité
DK3286176T3 (da)	2015-04-24	2020-03-02	Pfizer	Krystallinske former af 1-((2r,4r)-2-(1h-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)ureamaleat
US10779980B2 (en)	2016-04-27	2020-09-22	Synerz Medical, Inc.	Intragastric device for treating obesity
JP2020164722A (ja) *	2019-03-29	2020-10-08	デクセリアルズ株式会社	接着剤組成物
HRP20240302T1 (hr)	2020-01-28	2024-05-10	Assia Chemical Industries Ltd	Postupci za pripremu glasdegiba i njegove soli i krutih oblika glasdegib maleata i postupak za njihovu pripremu
CN113248475B (zh) *	2020-02-11	2023-03-17	中国科学院上海药物研究所	一类杂环取代的苯并咪唑二聚体或其药学上可接受的盐、组合物及其用途
WO2021191278A1 (fr)	2020-03-26	2021-09-30	Lek Pharmaceuticals D.D.	Forme dimaléate de 1-((2r,4r)-2-(1h-benzo[d]imidazol-2-yl)-1-méthylpipéridine -4-yl)-3-(4-cyanophényl)urée
KR20230031285A (ko)	2020-06-26	2023-03-07	라퀄리아 파마 인코포레이티드	레티노이드와 암 치료제의 병용 요법이 효과적인 암 환자를 선별하는 방법 및 레티노이드와 암 치료제의 병용 의약
WO2023002362A1 (fr)	2021-07-22	2023-01-26	Pfizer Inc.	Traitement d'une malignité hématologique

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1638765A (zh) *	2001-07-27	2005-07-13	柯里斯公司	Hedgehog信号转导途径介质、其相关组合物以及应用
SI1499607T1 (sl) *	2001-12-04	2006-06-30	Actelion Pharmaceuticals Ltd	4-(piperidil- in pirolidil-alkil-ureido)-kinolinikot antagonisti receptorja urotensina II
TW200304820A (en) *	2002-03-25	2003-10-16	Avanir Pharmaceuticals	Use of benzimidazole analogs in the treatment of cell proliferation
PL377215A1 (pl) *	2002-10-17	2006-01-23	Amgen Inc.	Pochodne benzimidazolu oraz ich zastosowanie w charakterze ligandów receptora waniloidowego
WO2005042495A1 (fr)	2003-10-21	2005-05-12	Imclone Systems Incorporated	Composes de (benzimidazol-2-yl)-phenyl-phenyl-uree et procedes d'inhibition de l'activite de l'heparanase
EP1678145A2 (fr)	2003-10-28	2006-07-12	Vertex Pharmaceuticals Incorporated	Benzimidazoles convenant comme modulateurs des canaux ioniques
US7816369B2 (en) *	2004-11-03	2010-10-19	Curis, Inc.	Mediators of hedgehog signaling pathways, compositions and uses related thereto
DE102005012875B4 (de)	2005-03-19	2006-11-16	Sanofi-Aventis Deutschland Gmbh	Verwendung von Amino substituierten 8-N-Benzimidazolen
WO2006124780A2 (fr) *	2005-05-12	2006-11-23	Kalypsys, Inc.	Inhibiteurs de la b-raf kinase
WO2008064830A1 (fr)	2006-11-27	2008-06-05	Ucb Pharma, S.A.	Dérivés bicycliques et hétérobicycliques, leurs procédés de fabrication et leurs utilisations pharmaceutiques
WO2008075196A1 (fr)	2006-12-15	2008-06-26	Pfizer Products Inc.	Dérivés du benzamidazole
EA016888B1 (ru)	2007-06-29	2012-08-30	Пфайзер Инк.	Производные бензимидазола
WO2009154739A2 (fr)	2008-06-17	2009-12-23	Duke University	Modulateurs du récepteur smoothened
WO2010027746A2 (fr)	2008-08-25	2010-03-11	Irm Llc	Modulateurs de la voie hedgehog

2008
- 2008-06-16 EA EA200971104A patent/EA016888B1/ru unknown
- 2008-06-16 JP JP2010514162A patent/JP4567099B2/ja active Active
- 2008-06-16 KR KR1020107001991A patent/KR101143246B1/ko active IP Right Grant
- 2008-06-16 EP EP08762901.0A patent/EP2170860B9/fr active Active
- 2008-06-16 RS RS20161132A patent/RS55395B9/sr unknown
- 2008-06-16 AU AU2008272641A patent/AU2008272641B2/en active Active
- 2008-06-16 ME MEP-2009-349A patent/ME00962B/fr unknown
- 2008-06-16 MY MYPI20095266A patent/MY148636A/en unknown
- 2008-06-16 PL PL08762901T patent/PL2170860T3/pl unknown
- 2008-06-16 CA CA2690953A patent/CA2690953C/fr active Active
- 2008-06-16 CN CN200880022602XA patent/CN101687841B/zh active Active
- 2008-06-16 BR BRPI0813412A patent/BRPI0813412B8/pt active IP Right Grant
- 2008-06-16 SI SI200831707A patent/SI2170860T1/sl unknown
- 2008-06-16 ES ES08762901.0T patent/ES2609258T3/es active Active
- 2008-06-16 NZ NZ581889A patent/NZ581889A/en unknown
- 2008-06-16 LT LTEP08762901.0T patent/LT2170860T/lt unknown
- 2008-06-16 AP AP2009005089A patent/AP2377A/xx active
- 2008-06-16 WO PCT/IB2008/001575 patent/WO2009004427A2/fr active Application Filing
- 2008-06-16 DK DK08762901.0T patent/DK2170860T5/en active
- 2008-06-16 GE GEAP200811622A patent/GEP20125702B/en unknown
- 2008-06-16 PT PT87629010T patent/PT2170860T/pt unknown
- 2008-06-16 HU HUE08762901A patent/HUE030052T4/en unknown
- 2008-06-19 US US12/142,119 patent/US8148401B2/en active Active
- 2008-06-19 PA PA20088785401A patent/PA8785401A1/es unknown
- 2008-06-20 UY UY31164A patent/UY31164A1/es active IP Right Grant
- 2008-06-25 HN HN2008000974A patent/HN2008000974A/es unknown
- 2008-06-27 AR ARP080102792A patent/AR067346A1/es active IP Right Grant
- 2008-06-27 PE PE2008001105A patent/PE20090772A1/es active IP Right Grant
- 2008-06-27 PE PE2012000473A patent/PE20121010A1/es active IP Right Grant
- 2008-06-27 TW TW097124392A patent/TWI371451B/zh active
- 2008-06-27 CL CL2008001922A patent/CL2008001922A1/es unknown
2009
- 2009-11-30 IL IL202420A patent/IL202420A/en active IP Right Grant
- 2009-12-07 CR CR11150A patent/CR11150A/es unknown
- 2009-12-08 DO DO2009000278A patent/DOP2009000278A/es unknown
- 2009-12-14 EC EC2009009803A patent/ECSP099803A/es unknown
- 2009-12-18 NI NI200900219A patent/NI200900219A/es unknown
- 2009-12-21 GT GT200900328A patent/GT200900328A/es unknown
- 2009-12-21 CU CU2009000225A patent/CU23847B1/es active IP Right Grant
- 2009-12-23 CO CO09147462A patent/CO6160232A2/es unknown
- 2009-12-25 TN TNP2009000544A patent/TN2009000544A1/fr unknown
- 2009-12-29 MA MA32454A patent/MA31466B1/fr unknown
2010
- 2010-06-09 HK HK10105659.9A patent/HK1139658A1/xx unknown
- 2010-08-04 JP JP2010175465A patent/JP2010280693A/ja active Pending
2012
- 2012-02-24 US US13/404,169 patent/US8431597B2/en active Active
2016
- 2016-11-23 HR HRP20161562TT patent/HRP20161562T2/hr unknown
- 2016-12-14 CY CY20161101293T patent/CY1118650T1/el unknown
2020
- 2020-07-15 NL NL301057C patent/NL301057I2/nl unknown
- 2020-08-11 NO NO2020027C patent/NO2020027I1/no unknown
- 2020-08-12 CY CY2020028C patent/CY2020028I1/el unknown
- 2020-08-13 HU HUS2000031C patent/HUS2000031I1/hu unknown
- 2020-08-20 FR FR20C1038C patent/FR20C1038I2/fr active Active
- 2020-08-26 LT LTPA2020528C patent/LTC2170860I2/lt unknown

Also Published As

Publication number	Publication date
JP2010531869A (ja)	2010-09-30
IL202420A0 (en)	2010-06-30
CR11150A (es)	2010-02-08
CL2008001922A1 (es)	2009-01-02
HN2008000974A (es)	2011-01-24
HUS2000031I1 (hu)	2020-09-28
LT2170860T (lt)	2017-01-10
EA016888B1 (ru)	2012-08-30
NO2020027I1 (no)	2020-08-11
CY2020028I2 (el)	2020-11-25
PL2170860T3 (pl)	2017-05-31
KR20100028120A (ko)	2010-03-11
NI200900219A (es)	2010-03-11
PE20090772A1 (es)	2009-06-24
US8431597B2 (en)	2013-04-30
TN2009000544A1 (fr)	2011-03-31
KR101143246B1 (ko)	2012-05-18
DK2170860T5 (en)	2017-03-20
ES2609258T3 (es)	2017-04-19
CY1118650T1 (el)	2017-07-12
CO6160232A2 (es)	2010-05-20
CY2020028I1 (el)	2020-11-25
ECSP099803A (es)	2010-01-29
AP2377A (en)	2012-03-07
US8148401B2 (en)	2012-04-03
PA8785401A1 (es)	2009-01-23
BRPI0813412B8 (pt)	2021-05-25
LTPA2020528I1 (lt)	2020-09-25
UY31164A1 (es)	2009-01-30
TWI371451B (en)	2012-09-01
AU2008272641A1 (en)	2009-01-08
AU2008272641B2 (en)	2013-08-29
PT2170860T (pt)	2017-01-04
CA2690953C (fr)	2012-10-02
WO2009004427A2 (fr)	2009-01-08
RS55395B1 (sr)	2017-04-28
JP2010280693A (ja)	2010-12-16
CU23847B1 (es)	2012-10-15
DK2170860T3 (en)	2017-01-09
HUE030052T4 (en)	2017-06-28
CU20090225A7 (es)	2012-02-15
MY148636A (en)	2013-05-15
BRPI0813412A2 (pt)	2014-12-30
DOP2009000278A (es)	2009-12-31
SI2170860T1 (sl)	2017-01-31
GEP20125702B (en)	2012-12-10
CA2690953A1 (fr)	2009-01-08
EA200971104A1 (ru)	2010-06-30
EP2170860B1 (fr)	2016-11-02
NL301057I2 (nl)	2020-09-10
JP4567099B2 (ja)	2010-10-20
HRP20161562T1 (hr)	2016-12-30
WO2009004427A3 (fr)	2009-06-04
US20120157495A1 (en)	2012-06-21
PE20121010A1 (es)	2012-08-06
NZ581889A (en)	2011-05-27
AP2009005089A0 (en)	2009-12-31
CN101687841B (zh)	2013-07-10
GT200900328A (es)	2011-08-29
HRP20161562T2 (hr)	2017-04-21
HUE030052T2 (hu)	2017-04-28
NL301057I1 (nl)	2020-07-22
MA31466B1 (fr)	2010-06-01
US20090005416A1 (en)	2009-01-01
CN101687841A (zh)	2010-03-31
AR067346A1 (es)	2009-10-07
EP2170860B9 (fr)	2017-02-22
RS55395B9 (sr)	2020-01-31
IL202420A (en)	2014-05-28
FR20C1038I2 (fr)	2021-08-13
BRPI0813412B1 (pt)	2020-01-21
HK1139658A1 (en)	2010-09-24
ME00962B (fr)	2012-06-20
EP2170860A2 (fr)	2010-04-07
TW200911792A (en)	2009-03-16
LTC2170860I2 (lt)	2022-03-10

Publication	Publication Date	Title
FR20C1038I1 (fr)	2020-10-02
CN300728776S (zh)	2008-01-09	墙纸(35)
CN300726767S (zh)	2008-01-02	闭门器
CN300914514S (zh)	2009-04-29	装饰片材
CN300908356S (zh)	2009-04-15	蓄电池(5)
CN300878770S (zh)	2009-01-28	包装盒(珍品诸葛酿演义酒)
CN300863207S (zh)	2008-12-24	人造毛皮(花型9)
CN300852959S (zh)	2008-11-26	水稻插秧机
CN300838040S (zh)	2008-10-15	包(7d21518)
CN300836294S (zh)	2008-10-08	工具箱(十一)
CN300833855S (zh)	2008-10-01	酒瓶
CN300833048S (zh)	2008-10-01	警用制式刀具刀鞘
CN300814927S (zh)	2008-08-13	炉头(3)
CN300807994S (zh)	2008-07-30	鞋(70)
CN300798446S (zh)	2008-07-02	树脂童玩偶(五虎将)
CN300786180S (zh)	2008-06-04	纺织面料(35)
CN300772615S (zh)	2008-04-30	汽车前保险杠(a13c)
CN300730919S (zh)	2008-01-09	汽车灯具(xhj-007)
CN300730889S (zh)	2008-01-09	贴片式led(28103)
CN300730795S (zh)	2008-01-09	蜡烛(176)
CN300730725S (zh)	2008-01-09	手拧式动能发电电筒
CN300730678S (zh)	2008-01-09	烛台(88)
CN300730560S (zh)	2008-01-09	加湿器(pct)
CN300730337S (zh)	2008-01-09	标贴(1)
CN300730276S (zh)	2008-01-09	标记笔(遵爵马克笔)